SlideShare a Scribd company logo
EPIDEMIOLOGY OF CVD
Mr. Mahesh Chand
Lecturer
M.Sc. Nursing
OBJECTIVES
• 10th causes of death worldwide
• IHD death statistics
• According to UN reports numbers of of deaths
due to cvd in the year
• To know rising prevalence
• According NCHS
• Trends in various age group
• Pathogenesis CVD
• Facts CVD in India
Cont….
• Levels of prevention
• Risk factors in primary prevention
• Benefit of secondary prevention
• National program for prevention and control
of diabetes cvd and stroke
• Complementary alternative system (CAM)
Top 10 causes of death worldwide
Ischemic Heart Disease Death Statistics
Rising prevalence
Source : Report of the Registrar General of India.
National Commission on Macroeconomics and Health (NCMH) Background Papers 1996.
Largest share in non communicable
diseases
Source : National Council of Health Science data India 2005.
Trend in various age groups
Source : National Commission on Macroeconomics and Health (NCMH)
background papers , Sept 2005.
Pathogenesis of CVD
• Ischemic heart disease occurs when flow of
oxygen rich blood to the myocardium is
blocked.
• Atherosclerosis is commonest cause.
Image from: www.nhlbi.nih.gov/health/health-topics/topics/heartattack
Facts about CVD In India
• Public health estimate indicate –
– 60% of the world’s CVD burden.
– Involves relatively younger age.
– Smaller coronary arteries : High incidence of CVD.
– Diffuse distal disease
– Multi vessel disease
– High incidence in women.
High Mortality rate
Primary and Secondary Prevention
• Primary prevention : Prevention of onset of disease
in persons without symptoms.
• Primordial prevention : Prevention of risk factors
causative of the disease, thereby reducing the
likelihood of development of the disease.
• Secondary prevention : Prevention of death or
recurrence of disease in those who are already
symptomatic.
Risk Factors in Primary Prevention
• Non modifiable risk factors :
– Age.
– Gender.
– Race.
– Family history of CVD.
• Behavioral risk factors :
– Sedentary lifestyle.
– Unhealthy diet.
– Heavy alcohol or cigarette consumption.
• Physiological risk factors :
– Hypertension.
– Obesity.
– Hyperlipidemia.
– Diabetes.
Modifiable risk factors
Population & community wide risk reduction approach
• Populations with high rates of CVD :
– Western lifestyle.
– High-fat diet.
– Physical inactivity.
– Tobacco use.
• Requires public health services :
– Surveillance.
– Education.
– Organizational partnerships.
– Legislation/policy.
•Activities in a variety of community settings:
– Schools.
– Worksites.
– Healthcare facilities.
– Community worship places.
Targets of a population-
wide approach
Individual and High-Risk Approaches
• Primary Prevention Guidelines (1995) and Secondary
Prevention Guidelines (Revised 2001) released by the
American Heart Association provide advice regarding
risk factor assessment, lifestyle modification, and
pharmacologic interventions for specific risk factors.
• Barriers exist in the community and healthcare setting
that prevent efficient risk reduction.
• Surveys of CVD prevention-related services show
disappointing results regarding cholesterol reduction
therapy, smoking cessation etc.
Individual Risk Assessment
Careful assessment of medical history, physical
examination, laboratory examinations.
– Tobacco, diet, and physical activity history.
– Blood pressure, height/weight, waist/hip
circumference, BMI, lipid profile.
– Determination of global risk score.
Framingham Risk Algorithms
• Provides 10-year estimated risk of CHD :
Applicable to specific ages and persons.
• Different versions published: –
– Wilson 1998 version includes LDL-C (Age limit 30-74).
– NCEP III 2001 version :- Wider age range but does not
include diabetes.
– D’Agastino 2001 version includes diabetes. Applicable to
other ethnic groups.
NCEP : National Cholesterol Education Programme
Considerations for Secondary Prevention
• Framingham algorithms can be used for
prediction of recurrent CHD events over next 2
years.
• Important predictors of reinfarction /CHD death
over 10-years post-MI (Wong et al. 1989).
– Blood Pressure.
– Total cholesterol.
– Diabetes.
Secondary Prevention Strategies of
Proven Benefit
• AHA Secondary Prevention Statement outlines
recommended assessment, management, and
risk factor goal levels.
• Proven strategies include: –
– Cholesterol-lowering therapy.
– Blood pressure reduction.
– Antiplatelet therapy.
– Smoking cessation.
– Dietary therapy.
– Exercise.
AHA : American Heart Association
Tobacco quitting
• Number one preventable risk factor
• Health benefits of quitting smoking begin immediately
– Most effective is combined pharmacologic and behavioral
strategies
• Governmental prevention programs including package health
warning labels and graphics.
Dietary Strategies
 Home cooked meals.
 Preferred versus restaurant and fast food.
 Carbohydrates.
 Recommend whole grains, barley, oats
 Roti is healthier option versus processed white rice.
 Proteins – Veg preferred.
 Veg Options include Soy, Tofu.
 White meats preferred over red meats.
 Fat - Prefer unsaturated fats like EPA/DHA & Alpha-Linoleic Acid.
 Nuts and fresh fish are excellent sources
 Avoid saturated fats such as ghee, margarine, coconut oils
 Don’t reuse cooking oil-this is unfortunately a common practice in India.
Cholesterol goals
• Diet and exercise are key!
• Total cholesterol goal: <200 mg/dL
• LDL (bad cholesterol) goal: <100 mg/dL
• Triglycerides Goal: <150 mg/dL
• HDL (good cholesterol) goal:
– >40 mg/dL in men, >50 mg/dL for women
National Heart Lung and Blood Institute: www.nhlbi.nih.gov/guidelines/cholesterol/index.htm
Exercise
• 30 minutes of moderate activity most days of
week.
– Helps lower BP.
– Diabetes.
– Raises good cholesterol (HDL).
– Manages stress.
– Improves bone health.
– Helps control weight.
Blood Pressure
• Quick screening recommended during all
healthcare visits .
• Controlling hypertension reduces risk of heart
disease by 25%
– Strategies include weight loss (i.e. via weight loss,
exercise, diet), low sodium in diet, limit alcohol
• Goal BP: <120 systolic and <80 diastolic
pressures
American Heart Association website: www.americanheart.org
Diabetes
• Optimal fasting blood sugar is< 100 mg/dL
• Criteria for Diagnosis of Diabetes -
– Fasting glucose 126 mg/dL or higher
– Random glucose of 200 mg/dL or higher + symptoms
• Goal to detect patients at level of impaired fasting
glucose of 100-125 mg/dL
• Individuals at risk of developing the disease can
prevent it by modest diet and exercise plan.
American Diabetes Association website: www.diabetes.org
National Programme for Prevention and Control
of Diabetes, Cardiovascular Disease and Stroke
• The evidence-based recommendations given in these
guidelines provide guidance on specific preventive actions to
initiate, and with what degree of intensity.
• The accompanying World Health Organization/ International
Society of Hypertension (WHO/ISH) risk prediction charts
enable the estimation of total cardiovascular risk .
National Programme for Prevention and Control
of Diabetes, Cardiovascular Disease and Stroke
• Settings –
Primary care and other levels of care including low resource settings.
• Resource Needs -
• Human resources: Medical doctors and health workers.
• Equipment:
– Stethoscope.
– Blood pressure measurement device.
– Measuring tape.
– Weighing machine.
– Equipment for testing urine glucose and urine albumin.
– Assay of blood glucose and lipid profile.
–
• Drugs:
– Thiazide diuretics.
– Beta blocker.
– Angiotensin converting enzyme inhibitors.
– Calcium channel blockers.
– Aspirin.
– Metformin, Glibenclamide, Insulin.
– Statins.
10 year risk of cardiovascular event Risk classification Intervention
Risk <10% Low risk
Encourage for lifestyle modification
(promote healthy diet, physical activity,
say no to tobacco and alcohol) Risk
assessed after 5 years unless significant
change in health status. Refer to
medical doctors for evaluation and
management
Risk 10% to <20% Moderate risk
Monitor risk profile every 2 years.
Encourage for lifestyle modification
(promote healthy diet, physical activity,
say no to tobacco and alcohol) Refer to
medical doctors for evaluation and
management
Risk 20% to <30% High risk
Monitor risk profile yearly. Encourage
for lifestyle modification (promote
healthy diet, physical activity, say no to
tobacco and alcohol) Refer to medical
doctors for evaluation and
management
Risk ≥30% Very High risk
Individuals in this category are at very
high risk of fatal or non-fatal vascular
events Monitor risk profile every 3–6
months Encourage for lifestyle
modification (promote healthy diet,
physical activity, say no to tobacco and
alcohol) Refer to medical doctors for
evaluation and management
Complementary and Alternative
Medicine (CAM)
• Biologically-based therapies.
• Mind-body therapies.
• Manipulative and body-based therapies.
• Whole medical systems.
• Energy medicine.
Biologically-Based Therapies
• Aromatherapy.
• Chelation therapy.
• Diet-based therapies.
• Folk medicine.
• Iridology.
• Megavitamin therapy.
• Neural therapy.
• Phytotherapy /herbal medicine.
Mind-Body Therapies (MBT)
• Anthroposophical medicine.
• Autogenic training.
• Biofeedback.
• Bio resonance.
• Cognitive-behavioral therapies.
• Deep-breathing exercises.
• Group support.
• Hypnosis.
• Imagery.
• Meditation.
• Prayer & relaxation.
Manipulative and Body-Based
Therapies
• Acupressure.
• Alexander technique.
• Bowen technique.
• Chiropractic manipulation.
• Feldenkrais method.
• Massage.
• Osteopathic manipulation.
• Reflexology.
• Rolfing.
• Trager bodywork.
Whole Medical Systems
• Acupuncture.
• Ayurveda.
• Homeopathy.
• Naturopathy.
Energy Medicine
• Healing touch.
• Light therapy.
• Magnetic therapy.
• Millimeter wave therapy.
• Qigong.
• Reiki.
• Sound energy therapy.
Summary Guidelines
Cerebro vascular diseases
Cerebro vascular diseases
Cerebro vascular diseases
Cerebro vascular diseases
Cerebro vascular diseases

More Related Content

What's hot

P001-Management of Dyslipidemia
P001-Management of DyslipidemiaP001-Management of Dyslipidemia
P001-Management of Dyslipidemia
Syameer Firdaus
 
Non communicable diseases
Non communicable diseasesNon communicable diseases
Non communicable diseases
Devipriya Viswambharan
 
Non communicable Disease Perspective : Bangladesh
Non communicable Disease Perspective : BangladeshNon communicable Disease Perspective : Bangladesh
Non communicable Disease Perspective : Bangladesh
Mohammad Arifur Rahman
 
Lifestyle Modification For The Prevention of Heart Disease
Lifestyle Modification For The Prevention of Heart DiseaseLifestyle Modification For The Prevention of Heart Disease
Lifestyle Modification For The Prevention of Heart Disease
Adarsha Neupane
 
د فيصل الناصر
د فيصل الناصرد فيصل الناصر
د فيصل الناصر
Albert Seo
 
Introduction to NCDs
Introduction to NCDsIntroduction to NCDs
Introduction to NCDs
Dr.Harsavardhan Nayak
 
Prevention deck 1 with voice
Prevention deck 1 with voicePrevention deck 1 with voice
Prevention deck 1 with voicemarkovich4
 
Epidemiology of the Hypertension
Epidemiology of the HypertensionEpidemiology of the Hypertension
Epidemiology of the Hypertension
Swasthavritta Akhandanad
 
Resiko metabolik
Resiko metabolik Resiko metabolik
Resiko metabolik
Ronald David Martua
 
Groupproject
GroupprojectGroupproject
Groupproject
Kassandra Bragg
 
Dr. Haireen Abdul Hadi - Global Public Health 2015
Dr. Haireen Abdul Hadi - Global Public Health 2015Dr. Haireen Abdul Hadi - Global Public Health 2015
Dr. Haireen Abdul Hadi - Global Public Health 2015
International Center for Research & Development
 
Epidemiology of Coronary Heart Diseases (CHD)
Epidemiology of Coronary Heart Diseases (CHD)Epidemiology of Coronary Heart Diseases (CHD)
Epidemiology of Coronary Heart Diseases (CHD)
Swasthavritta Akhandanad
 
Coronary heart disease
Coronary heart diseaseCoronary heart disease
Coronary heart disease
drsanjeev15
 
Non communicable disease and risk factors
Non communicable disease and risk factorsNon communicable disease and risk factors
Non communicable disease and risk factors
Rabin Dani
 
PEShare.co.uk Shared Resource
PEShare.co.uk Shared ResourcePEShare.co.uk Shared Resource
PEShare.co.uk Shared Resourcepeshare.co.uk
 
Non communicable disease
Non communicable diseaseNon communicable disease
Non communicable disease
Rozelle Mae Birador
 
Global Burden of Coronary Heart Disease
Global Burden of Coronary Heart DiseaseGlobal Burden of Coronary Heart Disease
Global Burden of Coronary Heart Disease
PERKI Pekanbaru
 
Epidemiology of coronary artery disease
Epidemiology of coronary artery diseaseEpidemiology of coronary artery disease
Epidemiology of coronary artery disease
Harivansh Chopra
 
Epid of ncd + htn
Epid of ncd + htnEpid of ncd + htn
Epid of ncd + htn
Rupam Kumar
 

What's hot (20)

P001-Management of Dyslipidemia
P001-Management of DyslipidemiaP001-Management of Dyslipidemia
P001-Management of Dyslipidemia
 
Non communicable diseases
Non communicable diseasesNon communicable diseases
Non communicable diseases
 
Non communicable Disease Perspective : Bangladesh
Non communicable Disease Perspective : BangladeshNon communicable Disease Perspective : Bangladesh
Non communicable Disease Perspective : Bangladesh
 
Lifestyle Modification For The Prevention of Heart Disease
Lifestyle Modification For The Prevention of Heart DiseaseLifestyle Modification For The Prevention of Heart Disease
Lifestyle Modification For The Prevention of Heart Disease
 
د فيصل الناصر
د فيصل الناصرد فيصل الناصر
د فيصل الناصر
 
Introduction to NCDs
Introduction to NCDsIntroduction to NCDs
Introduction to NCDs
 
Prevention deck 1 with voice
Prevention deck 1 with voicePrevention deck 1 with voice
Prevention deck 1 with voice
 
Epidemiology of the Hypertension
Epidemiology of the HypertensionEpidemiology of the Hypertension
Epidemiology of the Hypertension
 
Resiko metabolik
Resiko metabolik Resiko metabolik
Resiko metabolik
 
Groupproject
GroupprojectGroupproject
Groupproject
 
Dr. Haireen Abdul Hadi - Global Public Health 2015
Dr. Haireen Abdul Hadi - Global Public Health 2015Dr. Haireen Abdul Hadi - Global Public Health 2015
Dr. Haireen Abdul Hadi - Global Public Health 2015
 
Epidemiology of Coronary Heart Diseases (CHD)
Epidemiology of Coronary Heart Diseases (CHD)Epidemiology of Coronary Heart Diseases (CHD)
Epidemiology of Coronary Heart Diseases (CHD)
 
Coronary heart disease
Coronary heart diseaseCoronary heart disease
Coronary heart disease
 
Non communicable disease and risk factors
Non communicable disease and risk factorsNon communicable disease and risk factors
Non communicable disease and risk factors
 
PH+POSTER-2
PH+POSTER-2PH+POSTER-2
PH+POSTER-2
 
PEShare.co.uk Shared Resource
PEShare.co.uk Shared ResourcePEShare.co.uk Shared Resource
PEShare.co.uk Shared Resource
 
Non communicable disease
Non communicable diseaseNon communicable disease
Non communicable disease
 
Global Burden of Coronary Heart Disease
Global Burden of Coronary Heart DiseaseGlobal Burden of Coronary Heart Disease
Global Burden of Coronary Heart Disease
 
Epidemiology of coronary artery disease
Epidemiology of coronary artery diseaseEpidemiology of coronary artery disease
Epidemiology of coronary artery disease
 
Epid of ncd + htn
Epid of ncd + htnEpid of ncd + htn
Epid of ncd + htn
 

Similar to Cerebro vascular diseases

2019 prevention-guideline-slides-gl-prevention
2019 prevention-guideline-slides-gl-prevention2019 prevention-guideline-slides-gl-prevention
2019 prevention-guideline-slides-gl-prevention
PHAM HUU THAI
 
CAD -RISK FACTOR MODIFICATION AND PRIMARY PREVENTION
CAD -RISK FACTOR MODIFICATION AND PRIMARY PREVENTIONCAD -RISK FACTOR MODIFICATION AND PRIMARY PREVENTION
CAD -RISK FACTOR MODIFICATION AND PRIMARY PREVENTION
Praveen Nagula
 
cadprimaryprevention-ppt.pptx
cadprimaryprevention-ppt.pptxcadprimaryprevention-ppt.pptx
cadprimaryprevention-ppt.pptx
dkapila2002
 
cadprimaryprevention-ppt.pptx
cadprimaryprevention-ppt.pptxcadprimaryprevention-ppt.pptx
cadprimaryprevention-ppt.pptx
dkapila2002
 
CVD Risk asst Nursing lecture (2).pptx
CVD Risk asst Nursing lecture (2).pptxCVD Risk asst Nursing lecture (2).pptx
CVD Risk asst Nursing lecture (2).pptx
jiregnaetichadako
 
CORONARY ARTERY DISEASE.pptx
CORONARY ARTERY DISEASE.pptxCORONARY ARTERY DISEASE.pptx
CORONARY ARTERY DISEASE.pptx
Ramya569989
 
CVD Risk asst Nursing lecture 2023.pdf
CVD Risk asst Nursing lecture 2023.pdfCVD Risk asst Nursing lecture 2023.pdf
CVD Risk asst Nursing lecture 2023.pdf
BatMan752678
 
LifestyleMedicineDefined.pptx
LifestyleMedicineDefined.pptxLifestyleMedicineDefined.pptx
LifestyleMedicineDefined.pptx
Leslie Casey
 
Prevention and Control of Non-Communicable diseases (NCDs).pptx
Prevention and Control of Non-Communicable diseases (NCDs).pptxPrevention and Control of Non-Communicable diseases (NCDs).pptx
Prevention and Control of Non-Communicable diseases (NCDs).pptx
Jaydeep Ghevariya
 
Million-Hearts-Initiative.pptx
Million-Hearts-Initiative.pptxMillion-Hearts-Initiative.pptx
Million-Hearts-Initiative.pptx
derek462361
 
Prevention and control of chronic diseases
Prevention and control of chronic diseasesPrevention and control of chronic diseases
Prevention and control of chronic diseases
Dr Ghaiath Hussein
 
STEP.ppt
STEP.pptSTEP.ppt
STEP.ppt
MALATESHUNDI1
 
Let food be thy medicine: Diet and disease
Let food be thy medicine: Diet and diseaseLet food be thy medicine: Diet and disease
Let food be thy medicine: Diet and disease
University of Calgary
 
Hypertension.pptx
Hypertension.pptxHypertension.pptx
Hypertension.pptx
nahin10
 
Dr Vivek Baliga - Chronic Disease Management In Heart Failure And Diabetes
Dr Vivek Baliga - Chronic Disease Management In Heart Failure And DiabetesDr Vivek Baliga - Chronic Disease Management In Heart Failure And Diabetes
Dr Vivek Baliga - Chronic Disease Management In Heart Failure And Diabetes
Dr Vivek Baliga
 
Lifestyle Failure To Avoid Med Use
Lifestyle Failure To Avoid Med UseLifestyle Failure To Avoid Med Use
Lifestyle Failure To Avoid Med Usebwolstenholme
 
2019 cardio vascular disease prevention-guidelines
2019 cardio vascular disease  prevention-guidelines 2019 cardio vascular disease  prevention-guidelines
2019 cardio vascular disease prevention-guidelines
DIPAK PATADE
 
2019-Prevention-Guideline-Slides-gl-prevention.ppt
2019-Prevention-Guideline-Slides-gl-prevention.ppt2019-Prevention-Guideline-Slides-gl-prevention.ppt
2019-Prevention-Guideline-Slides-gl-prevention.ppt
HimaniPandya16
 
Hypertension
HypertensionHypertension

Similar to Cerebro vascular diseases (20)

cpg prev cvd 17.pptx
cpg prev cvd 17.pptxcpg prev cvd 17.pptx
cpg prev cvd 17.pptx
 
2019 prevention-guideline-slides-gl-prevention
2019 prevention-guideline-slides-gl-prevention2019 prevention-guideline-slides-gl-prevention
2019 prevention-guideline-slides-gl-prevention
 
CAD -RISK FACTOR MODIFICATION AND PRIMARY PREVENTION
CAD -RISK FACTOR MODIFICATION AND PRIMARY PREVENTIONCAD -RISK FACTOR MODIFICATION AND PRIMARY PREVENTION
CAD -RISK FACTOR MODIFICATION AND PRIMARY PREVENTION
 
cadprimaryprevention-ppt.pptx
cadprimaryprevention-ppt.pptxcadprimaryprevention-ppt.pptx
cadprimaryprevention-ppt.pptx
 
cadprimaryprevention-ppt.pptx
cadprimaryprevention-ppt.pptxcadprimaryprevention-ppt.pptx
cadprimaryprevention-ppt.pptx
 
CVD Risk asst Nursing lecture (2).pptx
CVD Risk asst Nursing lecture (2).pptxCVD Risk asst Nursing lecture (2).pptx
CVD Risk asst Nursing lecture (2).pptx
 
CORONARY ARTERY DISEASE.pptx
CORONARY ARTERY DISEASE.pptxCORONARY ARTERY DISEASE.pptx
CORONARY ARTERY DISEASE.pptx
 
CVD Risk asst Nursing lecture 2023.pdf
CVD Risk asst Nursing lecture 2023.pdfCVD Risk asst Nursing lecture 2023.pdf
CVD Risk asst Nursing lecture 2023.pdf
 
LifestyleMedicineDefined.pptx
LifestyleMedicineDefined.pptxLifestyleMedicineDefined.pptx
LifestyleMedicineDefined.pptx
 
Prevention and Control of Non-Communicable diseases (NCDs).pptx
Prevention and Control of Non-Communicable diseases (NCDs).pptxPrevention and Control of Non-Communicable diseases (NCDs).pptx
Prevention and Control of Non-Communicable diseases (NCDs).pptx
 
Million-Hearts-Initiative.pptx
Million-Hearts-Initiative.pptxMillion-Hearts-Initiative.pptx
Million-Hearts-Initiative.pptx
 
Prevention and control of chronic diseases
Prevention and control of chronic diseasesPrevention and control of chronic diseases
Prevention and control of chronic diseases
 
STEP.ppt
STEP.pptSTEP.ppt
STEP.ppt
 
Let food be thy medicine: Diet and disease
Let food be thy medicine: Diet and diseaseLet food be thy medicine: Diet and disease
Let food be thy medicine: Diet and disease
 
Hypertension.pptx
Hypertension.pptxHypertension.pptx
Hypertension.pptx
 
Dr Vivek Baliga - Chronic Disease Management In Heart Failure And Diabetes
Dr Vivek Baliga - Chronic Disease Management In Heart Failure And DiabetesDr Vivek Baliga - Chronic Disease Management In Heart Failure And Diabetes
Dr Vivek Baliga - Chronic Disease Management In Heart Failure And Diabetes
 
Lifestyle Failure To Avoid Med Use
Lifestyle Failure To Avoid Med UseLifestyle Failure To Avoid Med Use
Lifestyle Failure To Avoid Med Use
 
2019 cardio vascular disease prevention-guidelines
2019 cardio vascular disease  prevention-guidelines 2019 cardio vascular disease  prevention-guidelines
2019 cardio vascular disease prevention-guidelines
 
2019-Prevention-Guideline-Slides-gl-prevention.ppt
2019-Prevention-Guideline-Slides-gl-prevention.ppt2019-Prevention-Guideline-Slides-gl-prevention.ppt
2019-Prevention-Guideline-Slides-gl-prevention.ppt
 
Hypertension
HypertensionHypertension
Hypertension
 

More from Mahesh Chand

IV cannulation
IV cannulationIV cannulation
IV cannulation
Mahesh Chand
 
How to develop self reported scale
How to develop self reported scaleHow to develop self reported scale
How to develop self reported scale
Mahesh Chand
 
How to develop self reported scale ppt
How to develop self reported scale pptHow to develop self reported scale ppt
How to develop self reported scale ppt
Mahesh Chand
 
Intercostal drainage tube insertion
Intercostal drainage tube insertionIntercostal drainage tube insertion
Intercostal drainage tube insertion
Mahesh Chand
 
Care of patient in a hospital settings
Care of patient in a hospital settingsCare of patient in a hospital settings
Care of patient in a hospital settings
Mahesh Chand
 
Legal and ethical issues in icu
Legal and ethical issues in icuLegal and ethical issues in icu
Legal and ethical issues in icu
Mahesh Chand
 
Infection control in intensive care unit
Infection control in intensive care unitInfection control in intensive care unit
Infection control in intensive care unit
Mahesh Chand
 
Burn first aid ppt
Burn first aid pptBurn first aid ppt
Burn first aid ppt
Mahesh Chand
 
Anesthesia ppt
Anesthesia pptAnesthesia ppt
Anesthesia ppt
Mahesh Chand
 
Fumigation
FumigationFumigation
Fumigation
Mahesh Chand
 
Legal aspects in OT
Legal aspects in OTLegal aspects in OT
Legal aspects in OT
Mahesh Chand
 
Sterilization and disinfection
Sterilization and disinfectionSterilization and disinfection
Sterilization and disinfection
Mahesh Chand
 
Pain management techniques
Pain management techniquesPain management techniques
Pain management techniques
Mahesh Chand
 
Cardiac assessment
Cardiac assessmentCardiac assessment
Cardiac assessment
Mahesh Chand
 
Organization and functions of nursing srvices and education
Organization and functions of nursing srvices and educationOrganization and functions of nursing srvices and education
Organization and functions of nursing srvices and education
Mahesh Chand
 
Thyroidstorm ppt
Thyroidstorm pptThyroidstorm ppt
Thyroidstorm ppt
Mahesh Chand
 
Acute respiratory failure ppt
Acute respiratory failure pptAcute respiratory failure ppt
Acute respiratory failure ppt
Mahesh Chand
 
Pulmonary tuberculosis
Pulmonary tuberculosisPulmonary tuberculosis
Pulmonary tuberculosis
Mahesh Chand
 
Chronic Obstructive pulmonary diasese
Chronic Obstructive pulmonary diaseseChronic Obstructive pulmonary diasese
Chronic Obstructive pulmonary diasese
Mahesh Chand
 
Pleural effusion
Pleural effusionPleural effusion
Pleural effusion
Mahesh Chand
 

More from Mahesh Chand (20)

IV cannulation
IV cannulationIV cannulation
IV cannulation
 
How to develop self reported scale
How to develop self reported scaleHow to develop self reported scale
How to develop self reported scale
 
How to develop self reported scale ppt
How to develop self reported scale pptHow to develop self reported scale ppt
How to develop self reported scale ppt
 
Intercostal drainage tube insertion
Intercostal drainage tube insertionIntercostal drainage tube insertion
Intercostal drainage tube insertion
 
Care of patient in a hospital settings
Care of patient in a hospital settingsCare of patient in a hospital settings
Care of patient in a hospital settings
 
Legal and ethical issues in icu
Legal and ethical issues in icuLegal and ethical issues in icu
Legal and ethical issues in icu
 
Infection control in intensive care unit
Infection control in intensive care unitInfection control in intensive care unit
Infection control in intensive care unit
 
Burn first aid ppt
Burn first aid pptBurn first aid ppt
Burn first aid ppt
 
Anesthesia ppt
Anesthesia pptAnesthesia ppt
Anesthesia ppt
 
Fumigation
FumigationFumigation
Fumigation
 
Legal aspects in OT
Legal aspects in OTLegal aspects in OT
Legal aspects in OT
 
Sterilization and disinfection
Sterilization and disinfectionSterilization and disinfection
Sterilization and disinfection
 
Pain management techniques
Pain management techniquesPain management techniques
Pain management techniques
 
Cardiac assessment
Cardiac assessmentCardiac assessment
Cardiac assessment
 
Organization and functions of nursing srvices and education
Organization and functions of nursing srvices and educationOrganization and functions of nursing srvices and education
Organization and functions of nursing srvices and education
 
Thyroidstorm ppt
Thyroidstorm pptThyroidstorm ppt
Thyroidstorm ppt
 
Acute respiratory failure ppt
Acute respiratory failure pptAcute respiratory failure ppt
Acute respiratory failure ppt
 
Pulmonary tuberculosis
Pulmonary tuberculosisPulmonary tuberculosis
Pulmonary tuberculosis
 
Chronic Obstructive pulmonary diasese
Chronic Obstructive pulmonary diaseseChronic Obstructive pulmonary diasese
Chronic Obstructive pulmonary diasese
 
Pleural effusion
Pleural effusionPleural effusion
Pleural effusion
 

Recently uploaded

2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...
Sandy Millin
 
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
EugeneSaldivar
 
Synthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptxSynthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptx
Pavel ( NSTU)
 
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
siemaillard
 
Home assignment II on Spectroscopy 2024 Answers.pdf
Home assignment II on Spectroscopy 2024 Answers.pdfHome assignment II on Spectroscopy 2024 Answers.pdf
Home assignment II on Spectroscopy 2024 Answers.pdf
Tamralipta Mahavidyalaya
 
Embracing GenAI - A Strategic Imperative
Embracing GenAI - A Strategic ImperativeEmbracing GenAI - A Strategic Imperative
Embracing GenAI - A Strategic Imperative
Peter Windle
 
Supporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptxSupporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptx
Jisc
 
Unit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdfUnit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdf
Thiyagu K
 
Honest Reviews of Tim Han LMA Course Program.pptx
Honest Reviews of Tim Han LMA Course Program.pptxHonest Reviews of Tim Han LMA Course Program.pptx
Honest Reviews of Tim Han LMA Course Program.pptx
timhan337
 
The Accursed House by Émile Gaboriau.pptx
The Accursed House by Émile Gaboriau.pptxThe Accursed House by Émile Gaboriau.pptx
The Accursed House by Émile Gaboriau.pptx
DhatriParmar
 
How libraries can support authors with open access requirements for UKRI fund...
How libraries can support authors with open access requirements for UKRI fund...How libraries can support authors with open access requirements for UKRI fund...
How libraries can support authors with open access requirements for UKRI fund...
Jisc
 
678020731-Sumas-y-Restas-Para-Colorear.pdf
678020731-Sumas-y-Restas-Para-Colorear.pdf678020731-Sumas-y-Restas-Para-Colorear.pdf
678020731-Sumas-y-Restas-Para-Colorear.pdf
CarlosHernanMontoyab2
 
Sha'Carri Richardson Presentation 202345
Sha'Carri Richardson Presentation 202345Sha'Carri Richardson Presentation 202345
Sha'Carri Richardson Presentation 202345
beazzy04
 
Model Attribute Check Company Auto Property
Model Attribute  Check Company Auto PropertyModel Attribute  Check Company Auto Property
Model Attribute Check Company Auto Property
Celine George
 
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXXPhrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
MIRIAMSALINAS13
 
Digital Tools and AI for Teaching Learning and Research
Digital Tools and AI for Teaching Learning and ResearchDigital Tools and AI for Teaching Learning and Research
Digital Tools and AI for Teaching Learning and Research
Vikramjit Singh
 
1.4 modern child centered education - mahatma gandhi-2.pptx
1.4 modern child centered education - mahatma gandhi-2.pptx1.4 modern child centered education - mahatma gandhi-2.pptx
1.4 modern child centered education - mahatma gandhi-2.pptx
JosvitaDsouza2
 
Additional Benefits for Employee Website.pdf
Additional Benefits for Employee Website.pdfAdditional Benefits for Employee Website.pdf
Additional Benefits for Employee Website.pdf
joachimlavalley1
 
Acetabularia Information For Class 9 .docx
Acetabularia Information For Class 9  .docxAcetabularia Information For Class 9  .docx
Acetabularia Information For Class 9 .docx
vaibhavrinwa19
 
The Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official PublicationThe Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official Publication
Delapenabediema
 

Recently uploaded (20)

2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...
 
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
 
Synthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptxSynthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptx
 
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
 
Home assignment II on Spectroscopy 2024 Answers.pdf
Home assignment II on Spectroscopy 2024 Answers.pdfHome assignment II on Spectroscopy 2024 Answers.pdf
Home assignment II on Spectroscopy 2024 Answers.pdf
 
Embracing GenAI - A Strategic Imperative
Embracing GenAI - A Strategic ImperativeEmbracing GenAI - A Strategic Imperative
Embracing GenAI - A Strategic Imperative
 
Supporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptxSupporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptx
 
Unit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdfUnit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdf
 
Honest Reviews of Tim Han LMA Course Program.pptx
Honest Reviews of Tim Han LMA Course Program.pptxHonest Reviews of Tim Han LMA Course Program.pptx
Honest Reviews of Tim Han LMA Course Program.pptx
 
The Accursed House by Émile Gaboriau.pptx
The Accursed House by Émile Gaboriau.pptxThe Accursed House by Émile Gaboriau.pptx
The Accursed House by Émile Gaboriau.pptx
 
How libraries can support authors with open access requirements for UKRI fund...
How libraries can support authors with open access requirements for UKRI fund...How libraries can support authors with open access requirements for UKRI fund...
How libraries can support authors with open access requirements for UKRI fund...
 
678020731-Sumas-y-Restas-Para-Colorear.pdf
678020731-Sumas-y-Restas-Para-Colorear.pdf678020731-Sumas-y-Restas-Para-Colorear.pdf
678020731-Sumas-y-Restas-Para-Colorear.pdf
 
Sha'Carri Richardson Presentation 202345
Sha'Carri Richardson Presentation 202345Sha'Carri Richardson Presentation 202345
Sha'Carri Richardson Presentation 202345
 
Model Attribute Check Company Auto Property
Model Attribute  Check Company Auto PropertyModel Attribute  Check Company Auto Property
Model Attribute Check Company Auto Property
 
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXXPhrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
 
Digital Tools and AI for Teaching Learning and Research
Digital Tools and AI for Teaching Learning and ResearchDigital Tools and AI for Teaching Learning and Research
Digital Tools and AI for Teaching Learning and Research
 
1.4 modern child centered education - mahatma gandhi-2.pptx
1.4 modern child centered education - mahatma gandhi-2.pptx1.4 modern child centered education - mahatma gandhi-2.pptx
1.4 modern child centered education - mahatma gandhi-2.pptx
 
Additional Benefits for Employee Website.pdf
Additional Benefits for Employee Website.pdfAdditional Benefits for Employee Website.pdf
Additional Benefits for Employee Website.pdf
 
Acetabularia Information For Class 9 .docx
Acetabularia Information For Class 9  .docxAcetabularia Information For Class 9  .docx
Acetabularia Information For Class 9 .docx
 
The Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official PublicationThe Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official Publication
 

Cerebro vascular diseases

  • 1. EPIDEMIOLOGY OF CVD Mr. Mahesh Chand Lecturer M.Sc. Nursing
  • 2. OBJECTIVES • 10th causes of death worldwide • IHD death statistics • According to UN reports numbers of of deaths due to cvd in the year • To know rising prevalence • According NCHS • Trends in various age group • Pathogenesis CVD • Facts CVD in India
  • 3. Cont…. • Levels of prevention • Risk factors in primary prevention • Benefit of secondary prevention • National program for prevention and control of diabetes cvd and stroke • Complementary alternative system (CAM)
  • 4. Top 10 causes of death worldwide
  • 5. Ischemic Heart Disease Death Statistics
  • 6.
  • 7. Rising prevalence Source : Report of the Registrar General of India. National Commission on Macroeconomics and Health (NCMH) Background Papers 1996.
  • 8. Largest share in non communicable diseases Source : National Council of Health Science data India 2005.
  • 9. Trend in various age groups Source : National Commission on Macroeconomics and Health (NCMH) background papers , Sept 2005.
  • 10. Pathogenesis of CVD • Ischemic heart disease occurs when flow of oxygen rich blood to the myocardium is blocked. • Atherosclerosis is commonest cause.
  • 12. Facts about CVD In India • Public health estimate indicate – – 60% of the world’s CVD burden. – Involves relatively younger age. – Smaller coronary arteries : High incidence of CVD. – Diffuse distal disease – Multi vessel disease – High incidence in women. High Mortality rate
  • 13. Primary and Secondary Prevention • Primary prevention : Prevention of onset of disease in persons without symptoms. • Primordial prevention : Prevention of risk factors causative of the disease, thereby reducing the likelihood of development of the disease. • Secondary prevention : Prevention of death or recurrence of disease in those who are already symptomatic.
  • 14. Risk Factors in Primary Prevention • Non modifiable risk factors : – Age. – Gender. – Race. – Family history of CVD. • Behavioral risk factors : – Sedentary lifestyle. – Unhealthy diet. – Heavy alcohol or cigarette consumption. • Physiological risk factors : – Hypertension. – Obesity. – Hyperlipidemia. – Diabetes. Modifiable risk factors
  • 15. Population & community wide risk reduction approach • Populations with high rates of CVD : – Western lifestyle. – High-fat diet. – Physical inactivity. – Tobacco use. • Requires public health services : – Surveillance. – Education. – Organizational partnerships. – Legislation/policy. •Activities in a variety of community settings: – Schools. – Worksites. – Healthcare facilities. – Community worship places. Targets of a population- wide approach
  • 16. Individual and High-Risk Approaches • Primary Prevention Guidelines (1995) and Secondary Prevention Guidelines (Revised 2001) released by the American Heart Association provide advice regarding risk factor assessment, lifestyle modification, and pharmacologic interventions for specific risk factors. • Barriers exist in the community and healthcare setting that prevent efficient risk reduction. • Surveys of CVD prevention-related services show disappointing results regarding cholesterol reduction therapy, smoking cessation etc.
  • 17. Individual Risk Assessment Careful assessment of medical history, physical examination, laboratory examinations. – Tobacco, diet, and physical activity history. – Blood pressure, height/weight, waist/hip circumference, BMI, lipid profile. – Determination of global risk score.
  • 18. Framingham Risk Algorithms • Provides 10-year estimated risk of CHD : Applicable to specific ages and persons. • Different versions published: – – Wilson 1998 version includes LDL-C (Age limit 30-74). – NCEP III 2001 version :- Wider age range but does not include diabetes. – D’Agastino 2001 version includes diabetes. Applicable to other ethnic groups. NCEP : National Cholesterol Education Programme
  • 19. Considerations for Secondary Prevention • Framingham algorithms can be used for prediction of recurrent CHD events over next 2 years. • Important predictors of reinfarction /CHD death over 10-years post-MI (Wong et al. 1989). – Blood Pressure. – Total cholesterol. – Diabetes.
  • 20. Secondary Prevention Strategies of Proven Benefit • AHA Secondary Prevention Statement outlines recommended assessment, management, and risk factor goal levels. • Proven strategies include: – – Cholesterol-lowering therapy. – Blood pressure reduction. – Antiplatelet therapy. – Smoking cessation. – Dietary therapy. – Exercise. AHA : American Heart Association
  • 21.
  • 22. Tobacco quitting • Number one preventable risk factor • Health benefits of quitting smoking begin immediately – Most effective is combined pharmacologic and behavioral strategies • Governmental prevention programs including package health warning labels and graphics.
  • 23. Dietary Strategies  Home cooked meals.  Preferred versus restaurant and fast food.  Carbohydrates.  Recommend whole grains, barley, oats  Roti is healthier option versus processed white rice.  Proteins – Veg preferred.  Veg Options include Soy, Tofu.  White meats preferred over red meats.  Fat - Prefer unsaturated fats like EPA/DHA & Alpha-Linoleic Acid.  Nuts and fresh fish are excellent sources  Avoid saturated fats such as ghee, margarine, coconut oils  Don’t reuse cooking oil-this is unfortunately a common practice in India.
  • 24. Cholesterol goals • Diet and exercise are key! • Total cholesterol goal: <200 mg/dL • LDL (bad cholesterol) goal: <100 mg/dL • Triglycerides Goal: <150 mg/dL • HDL (good cholesterol) goal: – >40 mg/dL in men, >50 mg/dL for women National Heart Lung and Blood Institute: www.nhlbi.nih.gov/guidelines/cholesterol/index.htm
  • 25. Exercise • 30 minutes of moderate activity most days of week. – Helps lower BP. – Diabetes. – Raises good cholesterol (HDL). – Manages stress. – Improves bone health. – Helps control weight.
  • 26. Blood Pressure • Quick screening recommended during all healthcare visits . • Controlling hypertension reduces risk of heart disease by 25% – Strategies include weight loss (i.e. via weight loss, exercise, diet), low sodium in diet, limit alcohol • Goal BP: <120 systolic and <80 diastolic pressures American Heart Association website: www.americanheart.org
  • 27. Diabetes • Optimal fasting blood sugar is< 100 mg/dL • Criteria for Diagnosis of Diabetes - – Fasting glucose 126 mg/dL or higher – Random glucose of 200 mg/dL or higher + symptoms • Goal to detect patients at level of impaired fasting glucose of 100-125 mg/dL • Individuals at risk of developing the disease can prevent it by modest diet and exercise plan. American Diabetes Association website: www.diabetes.org
  • 28.
  • 29. National Programme for Prevention and Control of Diabetes, Cardiovascular Disease and Stroke • The evidence-based recommendations given in these guidelines provide guidance on specific preventive actions to initiate, and with what degree of intensity. • The accompanying World Health Organization/ International Society of Hypertension (WHO/ISH) risk prediction charts enable the estimation of total cardiovascular risk .
  • 30. National Programme for Prevention and Control of Diabetes, Cardiovascular Disease and Stroke • Settings – Primary care and other levels of care including low resource settings. • Resource Needs - • Human resources: Medical doctors and health workers. • Equipment: – Stethoscope. – Blood pressure measurement device. – Measuring tape. – Weighing machine. – Equipment for testing urine glucose and urine albumin. – Assay of blood glucose and lipid profile. – • Drugs: – Thiazide diuretics. – Beta blocker. – Angiotensin converting enzyme inhibitors. – Calcium channel blockers. – Aspirin. – Metformin, Glibenclamide, Insulin. – Statins.
  • 31. 10 year risk of cardiovascular event Risk classification Intervention Risk <10% Low risk Encourage for lifestyle modification (promote healthy diet, physical activity, say no to tobacco and alcohol) Risk assessed after 5 years unless significant change in health status. Refer to medical doctors for evaluation and management Risk 10% to <20% Moderate risk Monitor risk profile every 2 years. Encourage for lifestyle modification (promote healthy diet, physical activity, say no to tobacco and alcohol) Refer to medical doctors for evaluation and management Risk 20% to <30% High risk Monitor risk profile yearly. Encourage for lifestyle modification (promote healthy diet, physical activity, say no to tobacco and alcohol) Refer to medical doctors for evaluation and management Risk ≥30% Very High risk Individuals in this category are at very high risk of fatal or non-fatal vascular events Monitor risk profile every 3–6 months Encourage for lifestyle modification (promote healthy diet, physical activity, say no to tobacco and alcohol) Refer to medical doctors for evaluation and management
  • 32. Complementary and Alternative Medicine (CAM) • Biologically-based therapies. • Mind-body therapies. • Manipulative and body-based therapies. • Whole medical systems. • Energy medicine.
  • 33. Biologically-Based Therapies • Aromatherapy. • Chelation therapy. • Diet-based therapies. • Folk medicine. • Iridology. • Megavitamin therapy. • Neural therapy. • Phytotherapy /herbal medicine.
  • 34. Mind-Body Therapies (MBT) • Anthroposophical medicine. • Autogenic training. • Biofeedback. • Bio resonance. • Cognitive-behavioral therapies. • Deep-breathing exercises. • Group support. • Hypnosis. • Imagery. • Meditation. • Prayer & relaxation.
  • 35. Manipulative and Body-Based Therapies • Acupressure. • Alexander technique. • Bowen technique. • Chiropractic manipulation. • Feldenkrais method. • Massage. • Osteopathic manipulation. • Reflexology. • Rolfing. • Trager bodywork.
  • 36. Whole Medical Systems • Acupuncture. • Ayurveda. • Homeopathy. • Naturopathy.
  • 37. Energy Medicine • Healing touch. • Light therapy. • Magnetic therapy. • Millimeter wave therapy. • Qigong. • Reiki. • Sound energy therapy.